精品国产一区二区三区免费_亚洲国产精品综合久久20_中文字幕一区二区三区日韩精品_国产精品对白交换视频_国产午夜福利精品一区二区三区_国产精品亚洲一区二区三区久久_久久99精品国产99久久6男男_国产精品亚洲综合久久_国精产品一区一区三区有限在线,999国产高清在线精品-国产稀缺精品盗摄盗拍-国产精品一区二区久久久久久-999热在线精品观看全部-在线看片欧美日韩国产-亚洲天堂男人天堂-欧美激情麻豆精品一区二区,亚洲?V无码精品色午夜?V电影_精品一区二区三区影院在线午夜_精品亚洲综合一区二区三区香蕉_国产高清国产精品国产专区

供貨周期	現(xiàn)貨	規(guī)格	T-25 Flask
貨號(hào)	CBP73202	應(yīng)用領(lǐng)域	生物產(chǎn)業(yè)
主要用途	僅限科研使用

CBP73202
I. Introduction
Cell Line Name：	LMNA-NTRK1/BaF3
Host Cell:	BA/F3
Stability:	16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Application:	Anti-proliferation assay and PD assay
Freeze Medium:	90% FBS+10% DMSO
Complete Culture Medium:	RPMI-1640+10%FBS+2ug/ml puromycin
Mycoplasma Status:	Negative

II.Background
NTRK1 rearrangements involve the kinase domain of the NTRK1 gene which includes 17 exons located on chromosome 1q21-22 (Alberti et al. 2003). The frequency of NTRK1 fusions in patients with adenocarcinoma histology is 3.3% of cases (3 out of 91 patients; Vaishnavi et al. 2013). a In preclinical studies, cell lines expressing MPRIP-NTRK1 or CD74-NTRK1 were inhibited by ARRY-470, a TRKA/B/C inhibitor (Vaishnavi et al. 2013). b In preclinical studies, cell lines expressing MPRIP-NTRK1 or CD74-NTRK1 were inhibited by lestaurtinib, a FLT3/TRKA inhibitor (Vaishnavi et al. 2013). c A patient with non-small cell lung cancer harboring an MPRIP-NTRK1 fusion mutation was treated with crizotinib, which has activity against TRKA in addition to ALK, MET and ROS1 (Vaishnavi et al. 2013). The patient demonstrated a small radiographic decrease in tumor size but experienced disease progression after three months (Vaishnavi et al. 2013)

III. Representative Data
1. WB of LMNA-NTRK1/BaF3 expression



2. Sanger of LMNA-NTRK1/BaF3 expression Figure 2. Sanger Sequencing of LMNA-NTRK1/BaF3
3. Anti-proliferation assay

Figure 3. Anti-proliferation assay of two reference compounds on the LMNA-NTRK1/BaF3 Stable Cell Line